Changing Trends in Acute Osteomyelitis in Children
- 1 July 2008
- journal article
- selected topics
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Pediatric Orthopaedics
- Vol. 28 (5), 569-575
- https://doi.org/10.1097/bpo.0b013e31817bb816
Abstract
Background: Staphylococcus aureus remains the most common etiologic agent of acute osteomyelitis in children. Recently, methicillin-resistant S. aureus (MRSA) has emerged as a major pathogen. Methods: Records of all children admitted with acute osteomyelitis from January 1999 to December 2003 were reviewed. For the comparative analysis, the study population was evenly distributed in 2 periods: period A, January 1999 to June 2001; n = 113; and period B, July 2001 to December 2003; n = 177. In addition, clinical findings of MRSA osteomyelitis were compared with non-MRSA osteomyelitis, including methicillin-sensitive S. aureus infections. Results: Two hundred ninety children (60% male subjects) with acute osteomyelitis were identified. Median (25th-75th percentile) age at diagnosis was 6 years (range, 2-11 years). Significant clinical findings included the following: localized pain (84%), fever (67%), and swelling (62%). Affected bones included the following: foot (23%), femur (20%), tibia (16%), and pelvis (7%). Thirty-seven percent of blood cultures were positive, and a bacterial isolate was obtained in 55% of cases. Bacteria most frequently isolated included the following: methicillin-sensitive S. aureus (45%) (57% in period Avs 40% in period B), MRSA (23%) (6% in A vs 31% in B; P < 0.001), Streptococcus pyogenes (6%), and Pseudomonas aeruginosa (5%). Children with MRSA compared with those with non-MRSA osteomyelitis had significantly greater erythrocyte sedimentation rate and C-reactive protein values on admission and increased length of hospital stay, antibiotic therapy, and overall rate of complications. We observed significant changes in antibiotic therapy related to increased use of agents with activity against MRSA. Conclusions: Methicillin-resistant S. aureus was isolated more frequently in the second study period and was associated with worse clinical outcomes. Level of Evidence: II. Retrospective study.This publication has 33 references indexed in Scilit:
- Community-Acquired, Methicillin-Resistant and Methicillin-Susceptible Staphylococcus aureus Musculoskeletal Infections in ChildrenThe Pediatric Infectious Disease Journal, 2004
- Emergence of Community-Associated Methicillin-Resistant Staphylococcus aureus at a Memphis, Tennessee Children??s HospitalThe Pediatric Infectious Disease Journal, 2004
- MANAGEMENT OF ACUTE HEMATOGENOUS OSTEOMYELITIS IN CHILDRENThe Pediatric Infectious Disease Journal, 2004
- Prospective comparison of risk factors and demographic and clinical characteristics of community-acquired, methicillin-resistant versus methicillin-susceptible Staphylococcus aureus infection in childrenThe Pediatric Infectious Disease Journal, 2002
- Community-Acquired Methicillin-ResistantStaphylococcus aureus,FinlandEmerging Infectious Diseases, 2002
- The Changing Epidemiology of Staphylococcus aureus?Emerging Infectious Diseases, 2001
- Increase in Community‐Acquired Methicillin‐ResistantStaphylococcus aureusin ChildrenClinical Infectious Diseases, 1999
- Epidemiology and outcome of osteomyelitis in the era of sequential intravenous-oral therapyThe Pediatric Infectious Disease Journal, 1998
- Acute Osteomyelitis in ChildrenJournal of Pediatric Orthopaedics, 1990
- Osteomyelitis secondary to trauma or infected contiguous soft tissueThe Pediatric Infectious Disease Journal, 1988